Share-based Payment Arrangement, Expense in USD of Vanda Pharmaceuticals Inc. from 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Vanda Pharmaceuticals Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2010 to Q3 2025.
  • Vanda Pharmaceuticals Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2025 was $2.11M, a 29.6% decline year-over-year.
  • Vanda Pharmaceuticals Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2025 was $10.1M, a 21.7% decline year-over-year.
  • Vanda Pharmaceuticals Inc. annual Share-based Payment Arrangement, Expense for 2024 was $12.4M, a 11.5% decline from 2023.
  • Vanda Pharmaceuticals Inc. annual Share-based Payment Arrangement, Expense for 2023 was $14M, a 13.8% decline from 2022.
  • Vanda Pharmaceuticals Inc. annual Share-based Payment Arrangement, Expense for 2022 was $16.3M, a 5.89% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)

Vanda Pharmaceuticals Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $10.1M $2.11M -$887K -29.6% Jul 1, 2025 Sep 30, 2025 10-Q 2025-10-30
Q2 2025 $10.9M $2.11M -$880K -29.5% Apr 1, 2025 Jun 30, 2025 10-Q 2025-07-31
Q1 2025 $11.8M $2.97M -$613K -17.1% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-08
Q4 2024 $12.4M $2.86M -$410K -12.5% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-14
Q3 2024 $12.8M $3M -$168K -5.31% Jul 1, 2024 Sep 30, 2024 10-Q 2025-10-30
Q2 2024 $13M $2.99M -$263K -8.1% Apr 1, 2024 Jun 30, 2024 10-Q 2025-07-31
Q1 2024 $13.3M $3.58M -$767K -17.6% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-08
Q4 2023 $14M $3.27M -$510K -13.5% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-14
Q3 2023 $14.6M $3.17M -$721K -18.5% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $15.3M $3.25M -$581K -15.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 $15.9M $4.35M -$427K -8.94% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $16.3M $3.78M +$9K +0.24% Oct 1, 2022 Dec 31, 2022 10-K 2025-02-14
Q3 2022 $16.3M $3.89M -$63K -1.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $16.3M $3.83M +$90K +2.41% Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-28
Q1 2022 $16.2M $4.78M +$869K +22.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 $15.4M $3.77M +$562K +17.5% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-08
Q3 2021 $14.8M $3.95M +$816K +26% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $14M $3.74M +$671K +21.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $13.3M $3.91M -$35K -0.89% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 $13.4M $3.21M -$456K -12.4% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-09
Q3 2020 $13.8M $3.14M -$272K -7.98% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $14.1M $3.07M -$32K -1.03% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-29
Q1 2020 $14.1M $3.94M +$662K +20.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $13.5M $3.67M +$746K +25.5% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-24
Q3 2019 $12.7M $3.41M +$535K +18.6% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-29
Q2 2019 $12.2M $3.1M +$380K +14% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $11.8M $3.28M +$131K +4.16% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $11.7M $2.92M +$140K +5.03% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-11
Q3 2018 $11.5M $2.87M +$101K +3.65% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $11.4M $2.72M +$65K +2.45% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-01
Q1 2018 $11.4M $3.15M +$895K +39.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-03
Q4 2017 $10.5M $2.78M +$679K +32.3% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-26
Q3 2017 $9.79M $2.77M +$671K +32% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 $9.12M $2.66M +$582K +28.1% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-02
Q1 2017 $8.53M $2.26M -$10K -0.44% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-02
Q4 2016 $8.54M $2.1M +$216K +11.4% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-19
Q3 2016 $8.33M $2.1M +$39K +1.89% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 $8.29M $2.07M +$6K +0.29% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-03
Q1 2016 $8.28M $2.27M +$321K +16.5% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-03
Q4 2015 $7.96M $1.89M +$217K +13% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-15
Q3 2015 $7.74M $2.06M +$650K +46.1% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-03
Q2 2015 $7.09M $2.07M +$625K +43.3% Apr 1, 2015 Jun 30, 2015 10-Q 2016-07-28
Q1 2015 $6.47M $1.95M +$591K +43.6% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-05
Q4 2014 $5.88M $1.67M +$213K +14.6% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-17
Q3 2014 $5.67M $1.41M -$125K -8.14% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-04
Q2 2014 $5.79M $1.44M +$336K +30.4% Apr 1, 2014 Jun 30, 2014 10-Q 2015-07-31
Q1 2014 $5.45M $1.35M +$50K +3.83% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
Q4 2013 $5.4M $1.46M -$414K -22.1% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-12
Q3 2013 $5.82M $1.54M +$960K +167% Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-27
Q2 2013 $4.86M $1.11M -$81K -6.82% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-08
Q1 2013 $4.94M $1.3M -$87K -6.25% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q4 2012 $5.03M $1.87M Oct 1, 2012 Dec 31, 2012 10-K 2015-03-13
Q3 2012 $576K -$686K -54.4% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-08
Q2 2012 $1.19M -$126K -9.59% Apr 1, 2012 Jun 30, 2012 10-Q 2013-07-31
Q1 2012 $1.39M Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q3 2011 $1.26M Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-08
Q2 2011 $1.31M Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-03

Vanda Pharmaceuticals Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $12.4M -$1.61M -11.5% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-14
2023 $14M -$2.24M -13.8% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-14
2022 $16.3M +$905K +5.89% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-14
2021 $15.4M +$2.01M +15.1% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-08
2020 $13.4M -$98K -0.73% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-09
2019 $13.5M +$1.79M +15.4% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
2018 $11.7M +$1.2M +11.5% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-11
2017 $10.5M +$1.92M +22.5% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-26
2016 $8.54M +$582K +7.31% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-19
2015 $7.96M +$2.08M +35.4% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-15
2014 $5.88M +$474K +8.77% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-17
2013 $5.4M +$378K +7.52% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-12
2012 $5.03M -$460K -8.39% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-13
2011 $5.49M +$679K +14.1% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-25
2010 $4.81M Jan 1, 2010 Dec 31, 2010 10-K 2013-02-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.